Fazekas de St. Groth B - Search Results

1

EZH2 as a mediator of treatment resistance in melanoma.

Tiffen JC, Gallagher SJ, Tseng HY, Filipp FV, Fazekas de St. Groth B, Hersey P. Tiffen JC, et al. Pigment Cell Melanoma Res. 2016 Sep;29(5):500-7. doi: 10.1111/pcmr.12481. Epub 2016 May 25. Pigment Cell Melanoma Res. 2016. PMID: 27063195 Free PMC article. Review.

2

Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.

Lomax AJ, McGuire HM, McNeil C, Choi CJ, Hersey P, Karikios D, Shannon K, van Hal S, Carr U, Crotty A, Gupta SK, Hollingsworth J, Kim H, Fazekas de St Groth B, McGill N. Lomax AJ, et al. Int J Rheum Dis. 2017 Sep;20(9):1277-1285. doi: 10.1111/1756-185X.13076. Epub 2017 May 8. Int J Rheum Dis. 2017. PMID: 28480561

3

Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report.

McGuire HM, Shklovskaya E, Edwards J, Trevillian PR, McCaughan GW, Bertolino P, McKenzie C, Gourlay R, Gallagher SJ, Fazekas de St Groth B, Hersey P. McGuire HM, et al. Cancer Immunol Immunother. 2018 Apr;67(4):563-573. doi: 10.1007/s00262-017-2107-7. Epub 2017 Dec 30. Cancer Immunol Immunother. 2018. PMID: 29289977 Free PMC article.

4

Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients.

Pirozyan MR, McGuire HM, Emran AA, Tseng HY, Tiffen JC, Lee JH, Carlino MS, Menzies AM, Long GV, Scolyer RA, Fazekas de St Groth B, Hersey P. Pirozyan MR, et al. Front Immunol. 2020 Mar 10;11:372. doi: 10.3389/fimmu.2020.00372. eCollection 2020. Front Immunol. 2020. PMID: 32210968 Free PMC article.

5

Tumour-specific CD4 T cells eradicate melanoma via indirect recognition of tumour-derived antigen.

Shklovskaya E, Terry AM, Guy TV, Buckley A, Bolton HA, Zhu E, Holst J, Fazekas de St. Groth B. Shklovskaya E, et al. Immunol Cell Biol. 2016 Jul;94(6):593-603. doi: 10.1038/icb.2016.14. Epub 2016 Feb 3. Immunol Cell Biol. 2016. PMID: 26837456

6

Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand.

Berg LJ, Pullen AM, Fazekas de St Groth B, Mathis D, Benoist C, Davis MM. Berg LJ, et al. Cell. 1989 Sep 22;58(6):1035-46. doi: 10.1016/0092-8674(89)90502-3. Cell. 1989. PMID: 2476238

7

Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity.

Guy TV, Terry AM, Bolton HA, Hancock DG, Zhu E, Brink R, McGuire HM, Shklovskaya E, Fazekas de St. Groth B. Guy TV, et al. Oncotarget. 2016 May 24;7(21):30211-29. doi: 10.18632/oncotarget.8797. Oncotarget. 2016. PMID: 27121060 Free PMC article.

8

Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.

Guy TV, Terry AM, Bolton HA, Hancock DG, Shklovskaya E, Fazekas de St. Groth B. Guy TV, et al. Cancer Immunol Immunother. 2016 Aug;65(8):885-96. doi: 10.1007/s00262-016-1848-z. Epub 2016 May 24. Cancer Immunol Immunother. 2016. PMID: 27222052 Free PMC article. Review.

9

Balancing tolerance and immunity: the role of dendritic cell and T cell subsets.

Shklovskaya E, Fazekas de St Groth B. Shklovskaya E, et al. Methods Mol Biol. 2007;380:25-46. doi: 10.1007/978-1-59745-395-0_2. Methods Mol Biol. 2007. PMID: 17876085 Review.

10

Experimental models to investigate the function of dendritic cell subsets: challenges and implications.

Hancock DG, Guy TV, Shklovskaya E, Fazekas de St Groth B. Hancock DG, et al. Clin Exp Immunol. 2013 Feb;171(2):147-54. doi: 10.1111/cei.12027. Clin Exp Immunol. 2013. PMID: 23286941 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters